心臓発作ショック:現代的なアプローチと継続的な課題のレビュー

Lea R Goren¹, Xuan Ding¹, Maeve Jones-O'Connor¹

¹Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

|August 30, 2025

まとめ

心臓発作ショック (CS) の管理は複雑です. このレビューは,CSの定義,病理生理学,およびリヴァスキュラライゼーションやマイクロアクシアルフローポンプのような証拠に基づいた治療法をカバーし,知識のギャップと進行中の試験を強調しています.

科学分野:

心臓病科
クリティカルケア医療

背景:

心臓発作性ショック (CS) は,臓器不全につながる不十分な心臓発作による重大な状態である.
CSの異質性と分類を理解することは,効果的な管理に不可欠です.

研究の目的:

心臓発作ショックの定義,病理学,分類,管理について見直す.
CSの最近の進歩と証拠に基づいた治療アプローチを強調する.
CS管理における現在のエビデンス・ギャップと進行中の試験を特定する.

主な方法:

心臓発作ショックに関する文献のレビュー
CSのフェノタイプ異質性と分類における最近の進歩の分析.
証拠に基づいた治療介入と循環器のメカニカルサポート (MCS) 装置の評価

主要な成果:

エマージントリヴァスキュラライゼーションとマイクロアキシアルフローポンプは,特定のCS症例 (例えば,STEMI) で生存上の利点を示しています.
CSにおける他の医療療法とMCS装置に関する証拠は限られている.
証拠には大きなギャップがあり,現在進行中の試験は,将来の臨床実践に情報を提供する準備ができています.

結論:

心臓発作ショックを効果的に管理するには,その複雑な病理学と異質性を理解する必要があります.
限られた証拠に基づいた治療は,選択されたCS集団において生存上の利点を提供します.
CS治療の戦略を精進するためにさらなる研究と進行中の臨床試験が不可欠です

キーワード:

AMI-CS について心臓発作によるショック HF-CS 心臓発作性ショックの分類機械的循環支援

さらに関連する動画

07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.7K

06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

22.1K

関連する概念動画

01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...

01:24

Blood Pressure Imbalances and Circulatory Shock

998

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...

998

01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

01:17

Ischemic Heart Disease: Overview

1.4K

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...